Crystal Pharmatech reposted this
We’re excited to be represented by our strategic partner, CATUG, at the CRS 2024 Annual Meeting and Exposition in Italy. Meet with Cesare Di Nitto and Lin Jin to discuss the CATUG-Crystal RNA and LNP capabilities.
We are less than a week away from the CRS 2024 Annual Meeting & Expo! Will we see you there? Please reach out to Cesare Di Nitto or Lin Jin if you are interested in connecting. #CRS2024 #networking #pharma
The Crystal Pharmatech Formulation Forum continues this month on July 24th with guest speaker Chong-Hui Gu, Ph.D. This presentation will discuss protein degraders to address targets that were previously undruggable. Topics include: 🔹 Factors that limit oral absorption 🔹 Overcoming oral bioavailability challenges 🔹 Alternative routes to deliver protein degraders 📅 Register to attend July 24th at 2pm EDT: https://lnkd.in/eRHNPFyH Please note we cannot share the recording. Live attendance will be the only opportunity to view this presentation. #CrystalPharmatech #FormulationForum #PharmaceuticalScience #CMC #Biotech #DrugDevelopemnt #Formulation #Pharma #Research #Technology #API #CRO #CDMO
How can isostructural differences complicate XRPD characterization? Senior Scientist, Daniel Walters, PhD, discusses crystallographic considerations for isostructural phases, including: 🔹 Isostructural molecules vs isostructural phases 🔹 XRPD challenges for isostructural phases 🔹 Causes of diffractogram similarities for isostructural phases Subscribe on YouTube to keep up with the series: https://lnkd.in/ePfym9Xk #CrystalPharmatech #CrystalClassroom #Chemistry #PharmaceuticalScience #CMC #Biotech #DrugDevelopment #Research #Technology #API #CRO #CDMO
What actionable insights can be gained from physiologically based pharmacokinetic (PBPK) modeling? We previously detailed how Simulations Plus, Inc.'s GastroPlus® can be incorporated into a small molecule development program. We now dive into model-informed parameter sensitivity and how those insights can help guide development decisions. Parameters include: 🔹 Food effect 🔹 Solubility 🔹 Particle Size 🔹 Dose PBPK modeling with drug development experts offers a more efficient alternative to trial-and-error PK studies when looking to determine the effects of various parameters on bioavailability. Learn more at: https://lnkd.in/esmFC3Za #CrystalPharmatech #PharmaceuticalScience #CMC #Biotech #DrugDevelopment #Pharma #Research #Technology #API #CRO #CDMO
Congratulations to these future leaders in science and innovation! Crystal Pharmatech is proud to support the Acton-Boxborough Science Olympiad Team's participation at the Science Olympiad National Tournament in Michigan. These students achieved 5th out of 60 teams, reaching the highest ranking in their high school team's history. Great work!
In addition to previously covered instruments (PLM, TGA, DSC, XRPD), what other instruments are commonly used for API characterization? Subject Matter Expert, Derik McCarthy, covers additional instruments vital to API characterization such as: 🔹 High-Performance Liquid Chromatography (HPLC) 🔹 Particle Size Distribution Analyzer (PSD) 🔹 Karl Fischer Titration (KF) 🔹 Gas Chromatography (GC) Subscribe on YouTube to keep up with the series: https://lnkd.in/e69284yX #CrystalPharmatech #CrystalClassroom #XRPD #Chemistry #PharmaceuticalScience #CMC #Biotech #DrugDevelopment #Research #Technology #API #CRO #CDMO
It was a pleasure to present and discuss specialized formulation strategies at the 2024 Controlled & Modified Drug Release Summit this week in Princeton. We look forward to future opportunities to engage with drug innovators and advance pharmaceutical science through collaboration. #CrystalPharmatech #PharmaceuticalScience #CMC #Biotech #DrugDevelopment #Pharma #Research #Technology #API #CRO #CDMO
How can a technology-driven CRDMO incorporate physiologically based pharmacokinetic (PBPK) modeling into your small molecule program? Insights from Simulations Plus, Inc.’s GastroPlus® can be utilized by solid-state and formulation experts to optimize: 🔹 Lead candidate selection 🔹 GLP Tox formulation 🔹 FIH formulation An earlier understanding of the ADME profile for drug candidates can help innovators save time, money, and material. Learn more at: https://lnkd.in/eZkRNTUQ #CrystalPharmatech #PharmaceuticalScience #CMC #Biotech #DrugDevelopment #Pharma #Research #Technology #API #CRO #CDMO
